U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07705893) titled 'Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mg' on July 10.
Brief Summary: The objective of this study is to evaluate whether twice-daily use of Tyrvaya improves contact lens comfort in contact lens wearers.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Dry Eye
Intervention:
DRUG: Tyrvaya
Tyrvaya (varenicline solution 0.03 mg) is a nasal spray, which is dosed twice daily, that is indicated for treating signs and symptoms of dry eye disease (DED )This dropless ocular surface sparing dosing pattern is ideal for the busy CL patient because they can easily administer Tyrvaya twi...